Vytrus Biotech S.A Performance Comparison

Loading chart data...

Stock Range

Today's Range

Low: €5.60 High: €5.60
on August 8, 2025

52 Week Range

Low: €2.10 High: €6.05
on November 5, 2024
on July 31, 2025

All-Time High: €6.05 on July 31, 2025

Explore how other Spanish stocks compare to their 52-week ranges: View ES Market 52-Week Insights

Key Statistics

Market Cap i €41.4M
EPS i 0.14
P/E Ratio (TTM) i 39.29
Forward P/E i 16.14
P/B Ratio i 5.68
PEG Ratio i N/A
Div. Yield i N/A
ROE i 16.23%
Beta i 0.041
Debt to Equity i 24.31

Financial Highlights

Profitability

Gross Margin i N/A
Operating Margin i 15.45%
Profit Margin i 16.76%

Returns and Earnings

Return on Assets (TTM) i 6.02%
Return on Equity (TTM) i 16.23%
EBITDA i €1.8M
Net Income (TTM) i €1.0M

Growth

Revenue (TTM) i
Revenue Per Share (TTM) i €0.81
Quarterly Revenue Growth (YoY) i 38.70%
Quarterly Earnings Growth (YoY) i 174.30%

Peer Performance Comparison

Performance comparison table showing returns for peer companies over various time periods
CompanyMarket Cap1W1M3M6MYTD1Y3Y5Y
Vytrus Biotech S.A VYT 41.38M Small-cap-9.09%22.22%70.81%133.05%154.63%71.34%77.42%95.04%
Pharma Mar S.A PHM 1.41B Large-cap-1.68%-5.57%7.28%-13.02%-1.50%116.43%25.69%-6.61%
Atrys Health S.A ATRY 214.06M Mid-cap-4.11%8.95%-5.08%-21.79%-20.00%-7.89%-54.55%-62.57%
Biotechnology Assets BST 24.09M Small-cap0.00%-12.20%24.14%0.00%28.57%16.13%89.47%-53.85%
Oryzon Genomics S.A ORY 203.86M Mid-cap-2.65%-4.46%-3.38%72.48%71.33%48.57%1.17%-4.41%
Grifols, S.A GRF 7.93B Large-cap-2.06%22.50%57.28%54.08%35.84%46.52%-6.61%-47.55%

Ownership & Short Interest

Insider Ownership i 65.24%
Institutional Ownership i 1.69%
Shares Short i N/A
Short Ratio i N/A
Short % of Shares Outstanding i N/A
Average 10-Day Volume i 5K
Average 90-Day Volume i 5K

Vytrus Biotech S.A Recurring Investment / Dollar-Cost Averaging Calculator

Calculate how a regular investment in Vytrus Biotech S.A would have performed over time.

If not specified, the latest available data will be used

Note: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing.

Frequently Asked Questions

In the last 52 weeks, Vytrus Biotech S.A reached a high of €6.05 (on July 31, 2025) and a low of €2.10 (on November 5, 2024).
Curious about Vytrus Biotech S.A's size and valuation? Its market capitalization stands at 41.38M. When it comes to valuation, the P/E ratio (trailing twelve months) is 39.29, and the forward P/E (looking ahead) is 16.14.
As for dividends, Vytrus Biotech S.A isn't currently offering a significant yield, or that specific data isn't available right now.

When looking at Vytrus Biotech S.A, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:

CompanyMkt CapSectorIndustry1Y Return3Y Return
Pharma Mar S.A
PHM
1.41BHealthcareBiotechnology116.43%25.69%
Atrys Health S.A
ATRY
214.06MHealthcareBiotechnology-7.89%-54.55%
Biotechnology Assets
BST
24.09MHealthcareBiotechnology16.13%89.47%
Oryzon Genomics S.A
ORY
203.86MHealthcareBiotechnology48.57%1.17%
Grifols, S.A
GRF
7.93BHealthcareDrug Manufacturers - General46.52%-6.61%

For a more comprehensive list, please see the Peer Performance Comparison table on this page.

To get a sense of Vytrus Biotech S.A's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is 16.23%, the Debt to Equity ratio from the most recent quarter is 24.31, and its Gross Profit Margin stands at N/A.
Looking at Vytrus Biotech S.A's growth, its revenue over the trailing twelve months (TTM) was €6M. Compared to the same quarter last year (YoY), quarterly revenue grew by 38.70%, and quarterly earnings saw a YoY growth of 174.30%.
Wondering who owns Vytrus Biotech S.A stock? Company insiders (like executives and directors) hold about 65.24% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 1.69%.

For more common questions about our data, please visit our About Data page.

Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.